Blood tests for tau, a key biomarker of Alzheimer’s disease, may predict dementia risk, a new study found. How best to use ...
Research presented this week at the Alzheimer’s Association International Conference in London suggests that the use of blood ...
FDA-approved p-tau217/amyloid-beta-42 testing missed more amyloid PET-positive cases among older adults with prior TBI, a cross-sectional cohort study shows.
A blood test for the biomarker phosphorylated tau 217 (p-tau217) recently received federal clearance, but questions have ...